Literature DB >> 2547591

Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures.

G Hattersley1, T J Chambers.   

Abstract

The osteoclast is the cell that resorbs bone. It is known to derive from hemopoietic precursors, but analysis of lineage and regulation of differentiation has been hampered by lack of a specific marker that enables identification of cells of osteoclastic phenotype. Previously used markers, such as multinuclearity, that are specific for osteoclasts in bone become less specific in culture. Uniquely among bone and bone marrow cells, osteoclasts possess abundant calcitonin (CT) receptors. We therefore tested the correlation between the generation of bone-resorptive function and the formation of CT receptor-positive cells from hemopoietic tissue in vitro. Without 1,25-dihydroxy-vitamin D3 [1,25-(OH)2D3], a hormone that induces osteoclastic differentiation in vitro, bone marrow cultures showed very little bone resorption, and only small numbers of CT receptor-positive cells developed. When 1,25-(OH)2D3 was added to the cultures, CT receptor-positive cells developed within 1 day and reached a peak after 7 days. Bone resorption commenced within 2 days of hormone addition. There was a strong parallelism between the cumulative number of CT receptor-positive cells and the extent of bone resorption. The capacity of cultures to generate bone-resorptive activity and CT receptor-positive cells declined progressively when 1,25-(OH)2D3 was added to hemopoietic tissue after a 7- to 21-day hormone-free incubation period. The number of CT receptor-positive cells in these cultures correlated strongly (r = 0.96) with bone resorption. The behavior of these cultures suggests that 1,25-(OH)2D3 acts to induce terminal differentiation of osteoclast precursors present in the cultures, and that precursor cell numbers decreased with increasing time in vitro. All of the CT receptor-positive cells in control cultures and all of those seen shortly after 1,25-(OH)2D3 addition were mononuclear, despite considerable bone resorption; the majority of CT receptor-positive cells remained mononuclear throughout the incubation period. This suggests that mononuclear cells with characteristics of osteoclasts exist that are able to excavate bone. CT receptor-positive cells slightly preceded the development of bone-resorptive function, implying that CT receptors develop before the acquisition of bone-resorptive capacity by osteoclasts. Peritoneal macrophages, blood mononuclear cells, and cells of the J774 macrophage cell line failed to either resorb bone or express CT receptors, even after incubation with 1,25-(OH)2D3 for 14 days. These results show a strong and specific correlation between the generation of bone-resorptive cells and CT receptor-positive cells, and suggest that CT receptor express

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547591     DOI: 10.1210/endo-125-3-1606

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  34 in total

Review 1.  The final pathogenetic steps in focal bone erosions in rheumatoid arthritis.

Authors:  S R Goldring
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

2.  Avian osteoblast conditioned media stimulate bone resorption by targeting multinucleating osteoclast precursors.

Authors:  E M Greenfield; J I Alvarez; E A McLaurine; M J Oursler; H C Blair; P Osdoby; S L Teitelbaum; F P Ross
Journal:  Calcif Tissue Int       Date:  1992-10       Impact factor: 4.333

Review 3.  Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.

Authors:  P V Giannoudis; N K Kanakaris; T A Einhorn
Journal:  Osteoporos Int       Date:  2007-08-12       Impact factor: 4.507

4.  Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.

Authors:  N Udagawa; N Takahashi; T Akatsu; H Tanaka; T Sasaki; T Nishihara; T Koga; T J Martin; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells.

Authors:  R Pandey; J Quinn; C Joyner; D W Murray; J T Triffitt; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

6.  Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.

Authors:  D Jia; C A O'Brien; S A Stewart; S C Manolagas; R S Weinstein
Journal:  Endocrinology       Date:  2006-08-24       Impact factor: 4.736

7.  Catecholamines modulate growth and differentiation of human preosteoclastic cells.

Authors:  U Frediani; L Becherini; L Lasagni; A Tanini; M L Brandi
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

8.  Interleukin-11: a new cytokine critical for osteoclast development.

Authors:  G Girasole; G Passeri; R L Jilka; S C Manolagas
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

9.  Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells.

Authors:  A Matayoshi; C Brown; J F DiPersio; J Haug; Y Abu-Amer; H Liapis; R Kuestner; R Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts.

Authors:  W Hofstetter; A Wetterwald; M C Cecchini; R Felix; H Fleisch; C Mueller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.